Research assistance

We can help you find what you need. Call us or write us:
US: 800.298.5699
Int'l: +1.240.747.3093
Need help in your search?
 

Matching geography

Reports matching your search in:
 
 

Join Alert Me now!

Receive bi-weekly email alerts on new market research

Sign up today!
 

Biotechnology: market research reports

1594

The biotechnology industry encompasses the spectrum of life science-based research companies developing products and services for a wide variety of industries and applications. The industry holds the promise of transformative technologies from agriculture to materials science to environmental science to medicine. In agriculture, biotech products enhance crop yield, advance the nutritional value and quality of crops and livestock, and improve the efficacy and safety of pesticides.
In material science, biotechnology is adding to advances in polymer science and the coatings industry. In environmental science, biotech has contributed innovative solutions to environmental clean-up and waste management.

The biggest direct impact of biotechnology, and the biggest market for its products, is in medicine and healthcare. The biotechnology industry is, in many ways, becoming the research and development engine of the pharmaceutical industry. The tools and techniques of genetic analysis and manipulation are at the heart of the drug discovery process, and many of the largest biotech firms have been transformed over the past decade into pharmaceutical and biopharmaceutical giants.

The biotechnology category covers the companies, technologies, tools, and applications of the advanced life science sector. Included are reports on research methods and equipment such as liquid chromatography, mass spectroscopy, genetic sequencing, gene expression, etc. There are also reports on the business of biotechnology, mergers & acquisitions, and funding. Insofar as the sector intersects with the pharmaceutical industry, there are also reports on product pipelines, strategies for drug development and manufacturing such as biogenerics, biosimilars and biomanufacturing. Reports cover so-called green- and white-biotech sectors as well.

RSS Feeds

Biotechnology market research reports and industry analysis

< prev 3  4  5  6  7  8  9  10  11  12  next >
Proteomics Market (Protein Microarray, Mass Spectrometry, NMR, Chromatography, Electrophoresis, Surface Plasmon Resonance, Protein Fractionation, X-ray Crystallography, Immunoassay) Instruments, Reagents & Services, Trends & Forecasts to 2017
10/31/2012 | published by: MarketsandMarkets
... protein in a specific state of an organism to analyzing the interaction of proteins in living organisms. It also helps to map the modifications of proteins. Thus, it is evolving into an important tool in ...  |  more...
$4,650.00
Imugene Limited (IMU) - Financial and Strategic SWOT Analysis Review
10/30/2012 | published by: GlobalData
... health products for pigs and poultry, including vaccines and productivity enhancers. The company develops vaccines for the prevention of important livestock diseases and productivity enhancers to improve the economics of raising commercial livestock. Along with ...  |  more...
$125.00
Mycenax Biotech Inc. (4726) - Financial and Strategic SWOT Analysis Review
10/30/2012 | published by: GlobalData
... state-of-the-art facilities at Jhunan Science Park, Taiwan. This facility meets the latest international regulatory standards and it received the USFDA DMF Type V certification in 2005. Its services include consulting, research and development, cGMP manufacturing, ...  |  more...
$125.00
White Paper: DNA Sequencing Moves into Clinical Applications
10/26/2012 | published by: Kalorama Information
... medically-oriented projects.  As the cost of systems and consumables continues to drop, this has followed an exponential trend similar to Moore’s Law with computer chips and transistors.  In this White Paper, analyst Justin Saeks, who ...  |  more...
Autologous Stem Cell and Non-Stem Cell Based Therapies Market (2012-2017) (Neurodegenerative, cardiovascular, cancer & autoimmune, skin and infectious diseases)
10/26/2012 | published by: MarketsandMarkets
... as next pillar or advancement in medical care. Growth of the market is very rapid especially in regulatory approvals, applications areas and rapid improvements in efficacy of treatment; it has enormous advantages over allogenic stem ...  |  more...
$4,650.00
Generex Biotechnology Corporation (GNBT) - Financial and Strategic SWOT Analysis Review
10/23/2012 | published by: GlobalData
... virus, melanoma, ovarian cancer, HIV, HPV, allergy and Type I diabetes mellitus. It has a proprietary platform technology to deliver drugs into the human body through the oral cavity. The proprietary and proven advanced technology ...  |  more...
$125.00
Epistem Holdings Plc (EHP) - Financial and Strategic SWOT Analysis Review
10/23/2012 | published by: GlobalData
... healing. It operates through three reportable segments, namely, Contract Research Services, Novel Therapies and Personalised Medicine. It provides molecular biomarkers to measure drug induced gene expression from individual plucked hairs. It specializes in the marketing ...  |  more...
$125.00
Myriad Genetics, Inc. (MYGN) - Financial and Strategic SWOT Analysis Review
10/23/2012 | published by: GlobalData
... predictive medicine, prognostic medicine and personalized medicine products in the areas of oncology and CNS related disorders. Myriad Genetics, Inc. Key Recent Developments Aug 16, 2012: US Court of Appeals Upholds Myriad's Gene Patents Aug ...  |  more...
$125.00
Biotron Limited (BIT) - Financial and Strategic SWOT Analysis Review
10/23/2012 | published by: GlobalData
... research and development programs are used in treatment of hepatitis C virus (HCV), human immunodeficiency virus (HIV), Dengue virus and Influenza virus. Its offers a wide portfolio of clinical and preclinical antiviral programs that include ...  |  more...
$125.00
Corgenix Medical Corporation (CONX) - Financial and Strategic SWOT Analysis Review
10/23/2012 | published by: GlobalData
... sells 52 diagnostic products to clinical testing laboratories, biotechnology and pharmaceutical companies, hospitals, universities, and research institutions worldwide. The product portfolio includes antiphospholipid antibody testing products, hyaluronic acid tests, bleeding/clotting risk factors and ELISA autoimmune ...  |  more...
$125.00
Palatin Technologies, Inc. (PTN) - Financial and Strategic SWOT Analysis Review
10/23/2012 | published by: GlobalData
... of Palatin consists of active development programs targeting melanocortin and natriuretic receptors, including products to treat congestive heart failure, obesity, metabolic syndrome and sexual dysfunction. Palatin Technologies, Inc. Key Recent Developments Sep 11, 2012: Palatin ...  |  more...
$125.00
Bioneer Corporation (064550) - Financial and Strategic SWOT Analysis Review
10/23/2012 | published by: GlobalData
... research products of the company includes DNA/RNA amplification, DNA/RNA preparation, oligo synthesis & reagents, RNAi, enzymes, protein expression and purification, ladders and markers, yeast genome-wide library, drug target & toxicity, buffer & sequencing reagent and ...  |  more...
$250.00
Narhex Life Sciences Limited (NLS) - Financial and Strategic SWOT Analysis Review
10/23/2012 | published by: GlobalData
... DG17. DG17 is the water-soluble prodrug of the active anti-HIV drug DG35. NLS targets to develop DG17 for regulatory approval in OECD countries such as European Union, USA, Canada, Japan and Australia/New Zealand. It also ...  |  more...
$125.00
Advanced Proteome Therapeutics Corporation (APC) - Financial and Strategic SWOT Analysis Review
10/23/2012 | published by: GlobalData
... protein therapeutic market. It creates proprietary human protein pharmaceuticals with enhanced therapeutic properties by using protein modification technologies. APTC through its research and development activity applies leading edge chemical and biochemical methodologies to commercially viable ...  |  more...
$125.00
Celltrion, Inc. (068270) - Financial and Strategic SWOT Analysis Review
10/23/2012 | published by: GlobalData
... the treatment of breast cancer; CT-P13, is used to treat Crohn’s disease; CT-P10, is used for the treatment of Hodgkin’s lymphoma; for the treatment of Hodgkin’s lymphoma products; colon cancer products; respiratory syncytial virus products; ...  |  more...
$250.00
Parexel International Corporation (PRXL) - Financial and Strategic SWOT Analysis Review
10/23/2012 | published by: GlobalData
... Communications Services (PCMS). It offers a wide range of knowledge based contract research, consulting and medical communications services to the worldwide pharmaceutical, biotechnology and medical device markets. Parexel focuses on offering customized solutions that match ...  |  more...
$125.00
Genetic Technologies Limited (GTG) - Financial and Strategic SWOT Analysis Review
10/23/2012 | published by: GlobalData
... services genetic testing including cancer diagnostics, licensing, and research. The company offers genetic testing services for genetic testing of human, animal and plants. It offers genetic testing for parentage, disease susceptibility, individual identity, forensics and ...  |  more...
$125.00
genOway SA (ALGEN) - Financial and Strategic SWOT Analysis Review
10/23/2012 | published by: GlobalData
... consultancy services to its customers. genOway develops several technology platforms like safe DNA transgenesis, quick knock-in, safe in vivo RNAi and safe RNAi transgenesis. The company has a wide spread network with its operations being ...  |  more...
$125.00
Hybrigenics S.A. (ALHYG) - Financial and Strategic SWOT Analysis Review
10/23/2012 | published by: GlobalData
... identification, validation and inhibition of protein interactions. Its product pipeline is based on inecalcitol, a vitamin D receptor agonist being evaluated to treat prostate cancer, chronic lymphocytic leukemia and moderate to severe psoriasis. Hybrigenics S.A. ...  |  more...
$125.00
Global Biosimulation Technology Market (For Drug Discovery & Development) (2012 – 2017)
10/22/2012 | published by: MarketsandMarkets
... development. Biosimulation is used across the drug discovery and development program (such as target identification, target validation, lead discovery, lead optimization, preclinical and clinical test). The global biosimulation market was valued at $432.0 million in ...  |  more...
$4,650.00
Phosphagenics Limited : Ingredients - Company Profile, SWOT & Financial Report
10/21/2012 | published by: Canadean Ltd
... and services, swot analysis, business description, company history, key competitors, financial analysis, key employees, company locations and subsidiaries as well as employee biographies. Summary This report is a crucial resource for industry executives and anyone ...  |  more...
$125.00
Chenguang Biotech Group Co Ltd : Ingredients - Company Profile, SWOT & Financial Report
10/18/2012 | published by: Canadean Ltd
... key facts,major products and services, swot analysis, business description, company history, key competitors, financial analysis as well as key employees. Summary This report is a crucial resource for industry executives and anyone looking to access ...  |  more...
$125.00
U.S. qPCR and dPCR Instrumentation Markets
10/17/2012 | published by: Frost & Sullivan
... and dPCR just emerging. However, competitive expansion and pricing effects are significant topics for each. This research service offers a discussion of the key market drivers and restraints, a detailed analysis of the changing competitive ...  |  more...
$6,000.00
Biotechnology in the UK - Industry Market Research Report
10/17/2012 | published by: IBISWorld
... the industry include healthcare biotech companies, industrial biotech companies and agricultural biotech companies. This report covers the scope, size, disposition and growth of the industry including the key sensitivities and success factors. Also included are ...  |  more...
$870.00
Protein Kinase Inhibitors in Oncology Drug Pipeline Update 2012
10/16/2012 | published by: BioSeeker Group AB
... line of therapy. Given the fact that they all target tyrosine kinases and that kinase mutations can cause patients to become resistant to these drugs, there is plenty of room for more competition. There are ...  |  more...
$2,252.00
< prev 3  4  5  6  7  8  9  10  11  12  next >